Profile | GDS5420 / 227196_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 204.89 | 53 |
GSM1296119 | B_lesional_pre-dose | 1057 | 80 |
GSM1296076 | C_lesional_pre-dose | 1187.1 | 81 |
GSM1296092 | D_lesional_pre-dose | 1690.91 | 86 |
GSM1296103 | E_lesional_pre-dose | 318.77 | 60 |
GSM1296078 | F_lesional_pre-dose | 591.88 | 71 |
GSM1296107 | G_lesional_pre-dose | 1021.72 | 80 |
GSM1296109 | H_lesional_pre-dose | 104.93 | 40 |
GSM1296080 | I_lesional_pre-dose | 354.16 | 62 |
GSM1296090 | J_lesional_pre-dose | 1952.02 | 88 |
GSM1296074 | K_lesional_pre-dose | 713.91 | 74 |
GSM1296111 | L_lesional_pre-dose | 758.11 | 75 |
GSM1296099 | M_lesional_pre-dose | 935.2 | 78 |
GSM1296086 | O_lesional_pre-dose | 1000.01 | 79 |
GSM1296117 | P_lesional_pre-dose | 561.26 | 70 |
GSM1296113 | Q_lesional_pre-dose | 528.2 | 68 |
GSM1296096 | R_lesional_pre-dose | 589.25 | 70 |
GSM1296105 | S_lesional_pre-dose | 1663.86 | 87 |
GSM1296098 | T_lesional_pre-dose | 163.69 | 49 |
GSM1296101 | U_lesional_pre-dose | 285.07 | 58 |
GSM1296121 | V_lesional_pre-dose | 736.59 | 74 |
GSM1296088 | W_lesional_pre-dose | 529.66 | 69 |
GSM1296082 | X_lesional_pre-dose | 387.83 | 64 |
GSM1296115 | Y_lesional_pre-dose | 1140.81 | 81 |
GSM1296084 | Z_lesional_pre-dose | 1325.39 | 83 |
GSM1296072 | B_lesional_day8 | 1409.05 | 85 |
GSM1296069 | L_lesional_day8 | 1214.11 | 83 |
GSM1296071 | P_lesional_day8 | 1132.59 | 82 |
GSM1296070 | Y_lesional_day8 | 1611.1 | 87 |
GSM1296073 | V_lesional_day8 | 535.33 | 69 |
GSM1296034 | A_lesional_day15 | 223.84 | 53 |
GSM1296041 | G_lesional_day15 | 247.69 | 56 |
GSM1296035 | R_lesional_day15 | 268.86 | 57 |
GSM1296038 | U_lesional_day15 | 537.76 | 69 |
GSM1296047 | B_lesional_day15 | 2286.3 | 91 |
GSM1296039 | E_lesional_day15 | 137.48 | 47 |
GSM1296042 | H_lesional_day15 | 345.64 | 61 |
GSM1296043 | L_lesional_day15 | 1583.32 | 87 |
GSM1296037 | M_lesional_day15 | 4117.7 | 96 |
GSM1296046 | P_lesional_day15 | 1747.3 | 88 |
GSM1296044 | Q_lesional_day15 | 746.89 | 74 |
GSM1296045 | Y_lesional_day15 | 1840.85 | 89 |
GSM1296025 | C_lesional_day15 | 1242.39 | 82 |
GSM1296033 | D_lesional_day15 | 2471.87 | 92 |
GSM1296027 | I_lesional_day15 | 2970.14 | 93 |
GSM1296032 | J_lesional_day15 | 3865.51 | 96 |
GSM1296024 | K_lesional_day15 | 2104.77 | 90 |
GSM1296031 | W_lesional_day15 | 1537.54 | 86 |
GSM1296028 | X_lesional_day15 | 2754.78 | 93 |
GSM1296029 | Z_lesional_day15 | 1547.08 | 86 |
GSM1296026 | F_lesional_day15 | 399.28 | 64 |
GSM1296030 | O_lesional_day15 | 1137.5 | 81 |
GSM1296040 | S_lesional_day15 | 372.43 | 62 |
GSM1296036 | T_lesional_day15 | 178.73 | 49 |
GSM1296048 | V_lesional_day15 | 619.23 | 71 |
GSM1296059 | A_lesional_day43 | 324.48 | 61 |
GSM1296066 | G_lesional_day43 | 780.99 | 75 |
GSM1296060 | R_lesional_day43 | 781.2 | 75 |
GSM1296063 | U_lesional_day43 | 608.59 | 71 |
GSM1296064 | E_lesional_day43 | 872.94 | 77 |
GSM1296067 | H_lesional_day43 | 409.4 | 63 |
GSM1296062 | M_lesional_day43 | 1400.59 | 84 |
GSM1296068 | Q_lesional_day43 | 1448.99 | 86 |
GSM1296050 | C_lesional_day43 | 2671.37 | 92 |
GSM1296057 | D_lesional_day43 | 2403.07 | 92 |
GSM1296052 | I_lesional_day43 | 2282.92 | 90 |
GSM1296054 | J_lesional_day43 | 2767.64 | 94 |
GSM1296049 | K_lesional_day43 | 1897.68 | 88 |
GSM1296055 | W_lesional_day43 | 847.23 | 76 |
GSM1296053 | X_lesional_day43 | 1651.22 | 87 |
GSM1296058 | Z_lesional_day43 | 944.01 | 78 |
GSM1296051 | F_lesional_day43 | 1699.12 | 86 |
GSM1296056 | O_lesional_day43 | 380.53 | 64 |
GSM1296065 | S_lesional_day43 | 1446.61 | 85 |
GSM1296061 | T_lesional_day43 | 67.19 | 35 |
GSM1296095 | A_non-lesional_pre-dose | 187.75 | 52 |
GSM1296120 | B_non-lesional_pre-dose | 2532.96 | 92 |
GSM1296077 | C_non-lesional_pre-dose | 1778.92 | 87 |
GSM1296093 | D_non-lesional_pre-dose | 2596.95 | 93 |
GSM1296104 | E_non-lesional_pre-dose | 1667.19 | 86 |
GSM1296079 | F_non-lesional_pre-dose | 2151.81 | 90 |
GSM1296108 | G_non-lesional_pre-dose | 1223.8 | 83 |
GSM1296110 | H_non-lesional_pre-dose | 747.29 | 74 |
GSM1296081 | I_non-lesional_pre-dose | 4706.53 | 97 |
GSM1296091 | J_non-lesional_pre-dose | 4010.24 | 96 |
GSM1296075 | K_non-lesional_pre-dose | 1980.47 | 88 |
GSM1296112 | L_non-lesional_pre-dose | 2337.2 | 92 |
GSM1296100 | M_non-lesional_pre-dose | 5203.39 | 97 |
GSM1296087 | O_non-lesional_pre-dose | 3177.28 | 94 |
GSM1296118 | P_non-lesional_pre-dose | 3572.51 | 96 |
GSM1296114 | Q_non-lesional_pre-dose | 1170.85 | 82 |
GSM1296097 | R_non-lesional_pre-dose | 1288.84 | 83 |
GSM1296106 | S_non-lesional_pre-dose | 1640.29 | 87 |
GSM1296102 | U_non-lesional_pre-dose | 371.53 | 62 |
GSM1296122 | V_non-lesional_pre-dose | 1293.81 | 84 |
GSM1296089 | W_non-lesional_pre-dose | 2101.17 | 90 |
GSM1296083 | X_non-lesional_pre-dose | 2016.11 | 89 |
GSM1296116 | Y_non-lesional_pre-dose | 2037.09 | 90 |
GSM1296085 | Z_non-lesional_pre-dose | 4382.2 | 97 |